COMMON STOCK (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
6 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Jun. 21, 2023 |
Apr. 18, 2023 |
Apr. 10, 2023 |
Jan. 26, 2023 |
Jan. 24, 2023 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Apr. 09, 2023 |
Dec. 31, 2022 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||
| Offering issuance sale | 901,275 | ||||||||
| Offering price | $ 8.00 | ||||||||
| Proceeds from sale of common stock | $ 6,578 | $ 6,578 | $ 20,150 | ||||||
| Warrant exercise price per share | $ 13.60 | ||||||||
| Warrant exercise price decreased | $ 8.00 | ||||||||
| Offering issuance sale, value | |||||||||
| Common stock, shares authorized | 400,000,000 | 400,000,000 | 200,000,000 | 400,000,000 | |||||
| Stockholders' Equity, Reverse Stock Split | reverse stock split of its outstanding shares of common stock at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-forty (1-for-40) split. On April 18, 2023, the Company implemented the 1-for-40 reverse stock split (the “Reverse Stock Split”) of its common stock. The Company’s common stock commenced trading on a post- reverse stock split basis on April 19, 2023. As a result of the Reverse Stock Split, every forty (40) shares of the Company’s pre-Reverse Stock Split common stock were combined and reclassified into one share of common stock | ||||||||
| 2019 Incentive Compensation Plan [Member] | |||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||
| Number of shares authorized | 15,000,000 | ||||||||
| Equity Option [Member] | |||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||
| Number of ooptions granted | 997,595 | 8,090 | |||||||
| Options exercise price | $ 1.11 | $ 9.20 | |||||||
| Grant fair value of options | $ 953 | $ 66 | |||||||
| Stock option vesting period | 4 years | ||||||||
| Maximum [Member] | |||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||
| Offering issuance sale, value | $ 50,000 | ||||||||
| Common Stock [Member] | |||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||
| Offering issuance sale | 15,182 | ||||||||
| Shares issued | 197,414 | 11,581 | |||||||
| Offering issuance sale, value | |||||||||
| Stockholders' Equity, Reverse Stock Split | 1-for-40 reverse stock split | ||||||||
| Common Stock [Member] | Officer And Employees [Member] | |||||||||
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||
| Shares issued | 195,489 | ||||||||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options grants in period grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|